Business profile

Hahl-Lampenius Medical Oy

Hahl-Lampenius Medical Oy's registered office is Hollola. It is a limited company. The company was established on 2020-04-28. It operates in the industry of medical specialists activities. In its latest retained statement for 2025-12-31, revenue was €510,601 and operating profit was €266,989.

Claim profileContact details
Business ID 3131904-9ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3131904-9
Sector
Medical specialists activities
Municipality
Hollola
Company form
Limited company
Registration date
2020-04-28
Business ID registration date
2020-04-20
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Järventaustantie 174, 15880, Hollola

About Hahl-Lampenius Medical Oy

Financial position and key figures for the company.

Hahl-Lampenius Medical Oy's location municipality is Hollola. It is a limited company. The company was established on 2020-04-28. It operates in the industry of medical specialists activities. In its latest retained statement for 2025-12-31, revenue was €510,601 and operating profit was €266,989. The latest retained financial statement for 2025-12-31 shows revenue of €510,601 and profit for the financial year of €236,919. Based on the latest retained statement, revenue growth was -4.9%, operating margin was +52.3%, and equity ratio was +99.5%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-12-31

Imported periods2
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth-4.9%
Operating margin52.3%
Equity ratio99.5%
Balance-sheet contextLatest financial period
Other operating income€13,490Previous: €14,604
Cash and bank€153,681Previous: €234,112
Retained earnings€730,630Previous: €557,589
Equity€967,549Previous: €795,730
Liabilities€4,915Previous: €14,294
Current assets€205,254Previous: €290,622
Current liabilities€4,915Previous: €14,294
Revenue trend2 periods
€536,835
2024-12-31
€510,601
2025-12-31
Operating profit (loss) trend2 periods
€304,408
2024-12-31
€266,989
2025-12-31
Profit (loss) for the financial year trend2 periods
€238,141
2024-12-31
€236,919
2025-12-31
Assets trend2 periods
€810,024
2024-12-31
€972,465
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Improving
99.5 %2024-12-31: 98.2 %
Current ratioGood
100/100 · Improving
31.26x2024-12-31: 16.38x
Operating profit marginGood
100/100 · Declining
50.9 %2024-12-31: 55.2 %
Ratio history
Ratio2024-12-312025-12-31
Equity ratio98.2 %99.5 %
Current ratio16.38x31.26x
Operating profit margin55.2 %50.9 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3131904-9
EU IDFIFPRO.3131904-9
MunicipalityHollola
Current registered entries
2020-04-20Registered in Tax Administration (Prepayment Register)
2020-04-28Registered in Tax Administration (Tax Administration)
2020-04-28Registered in Patent and Registration Office (Trade Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A2
Very goodHahl-Lampenius Medical Oy
Grade unchangedA2 · new analysis 2026-10-18
Model score86/100
Assessment confidenceHigh
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectoryFinancial development is mostly stable or mixed.
2 comparable periods
RevenueStable
ProfitabilityDeteriorating
SolvencyStable
LiquidityImproving
Peer comparisonSame industry, size and age groupDescriptive comparison – does not change the model score.
174 peers
Solvency96%
Better than 96% of peers
Profitability69%
Better than 69% of peers
Liquidity90%
Better than 90% of peers
Revenue growth26%
Below 74% of peers
Financial statement reporting patternRegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
2 observed filings
Latest registration lag92 days after period end
Typical registration lag93 days after period end
Annual continuity2 consecutive periods
Supporting factors
  • Strong equity ratio
  • Strong operating profitability
  • Healthy short-term liquidity
Risk factors to note

No material separate warning signals.

Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessments
A2
2026-10-1886/100 · v0.15
A2 → A2
A2
2026-10-05 00:3086/100 · v0.14
B1 → A2 · +18 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2025-12-31).
  • Assessment confidence: Medium → High.
  • Evidence quality: Registry and statistical evidence → Strong financial evidence.
B1
2026-09-1568/100 · v0.14
B1 → B1 · +6 points
  • Assessment confidence: Low → Medium.
  • Evidence quality: Registry and statistical evidence → Registry and statistical evidence.
  • New risk factor: Sufficient structured financial metrics are not available.
B1
2026-09-1462/100 · v0.12
Oldest retained automatic assessment in this comparison
Automatic model gradeA2
Automatic model snapshot2026-10-18
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskvery low
94/100

Industry context is very low based on normalized open statistical inputs.

Age and continuityHyvä
60/100

The company has about 6 years of registry continuity.

Registry and status signalsSeurattava
56/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
18 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A2.
Risk grade updatedRisk gradeEvidence verified
5 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1 → A2.
Risk grade updatedRisk gradeEvidence verified
15 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.

Registry timeline

Trade register notifications shown on a timeline.

9 register eventsLatest event: 2026-04-02

Financial statements availability

Available financial statement periods and PRH source filings.

2 financial statement periodsLatest financial period: 2025-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Hahl-Lampenius Medical Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.